Patent application number | Description | Published |
20080255084 | Combination of Organic Compounds - The invention relates to a combination, such as a combined preparation or a pharmaceutical composition, respectively comprising
| 10-16-2008 |
20080261958 | Combination of Organic Compounds - The present invention relates to a combination comprising: (a) an angiotensin II receptor blocker (ARB), or a pharmaceutically acceptable salt thereof; (b) a calcium channel blocker (CCB), or a pharmaceutically acceptable salt thereof; and (c) one of the two active agents selected from (i) a rennin inhibitor, or a pharmaceutically acceptable salt thereof; and (ii) a neutral endopeptidase (NEP) inhibitor, or a pharmaceutically acceptable salt thereof; for the prevention of, delay the onset of and/or treatment of cardiovascular disorders, which method comprises administering to a warm-blooded animal, in need thereof, a therapeutically effective amount of a combination of the present invention. | 10-23-2008 |
20080262059 | METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITION - The invention relates a pharmaceutical composition comprising a combination of:
| 10-23-2008 |
20080300238 | PHARMACEUTICAL COMPOSITION COMPRISING A RENIN INHIBITOR, A CALCIUM CHANNEL BLOCKER AND A DIURETIC - The invention relates to a pharmaceutical composition comprising (i) a renin inhibitor, (ii) a calcium channel blocker (CCB), and a diuretic and to a method of using such composition for the treatment of cardiovascular disease. | 12-04-2008 |
20090005361 | Combination of Organic Compounds - The present invention relates to a combination, such as a combined preparation or pharmaceutical composition, respectively, comprising a therapeutic agent acting on the renin-angiotensin system (RAS) or a pharmaceutically acceptable salt thereof and comprising at least one CB1 antagonist, or a pharmaceutically acceptable salt thereof. The present invention furthermore relates to the use of such a combination for the prevention of, delay of progression of, treatment of diseases and disorders that may be modulated by action on the renin-angiotensin system (RAS), appetency disorders or substance abuse disorders. | 01-01-2009 |
20090099241 | PHARMACEUTICAL COMPOSITION CONTAINING ANTIHYPERTENSIVE AGENTS - The present invention relates to a combination of organic compounds, a pharmaceutical composition and a kit of parts comprising said combination of organic compounds and to a method of treatment or prevention of certain conditions or diseases. | 04-16-2009 |
20090247582 | METHODS OF TREATING ATHEROSCLEROSIS - The present invention relates to a method for the prevention, delay the onset and treatment of atherosclerosis which method comprises administering to a warm-blooded animal, in need thereof, a therapeutically effective amount of a renin inhibitor, or a pharmaceutically acceptable salt thereof, alone or in combination with at least one therapeutic agent selected from the group consisting of:
| 10-01-2009 |
20100048654 | USE OF VALSARTAN OR ITS METABOLITE TO IN HIBIT PLATELET AGGREGATION - The invention relates to a method of inhibiting platelet aggregation comprising administering a therapeutically effective amount of an ARB or its metabolite, especially Valsartan or its metabolite valeryl 4-hydroxy valsartan. Conditions to be treated by inhibition of platelet aggregation include acute myocardial infarction, ischemic stroke, angina pectoris, acute coronary syndromes, TIA (transient ischemic attacks, or acute cerebrovascular syndromes), heart failure, chest pain of ischemic etiology, syndrome X, thromboembolism, pulmonary hypertension, diabetes mellitus, peripheral vascular disease, deep vein thrombosis, arterial thrombosis of any vessel, catheter thrombotic occlusion or reocclusion. | 02-25-2010 |
20100196467 | THERAPEUTIC COMBINATION OF AMLODIPINE AND BENAZEPRIL/BENAZEPRILAT - The present invention especially relates to the use of a combination comprising | 08-05-2010 |
20120004312 | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases - The invention relates to a combination comprising the renin inhibitor of formula (I) | 01-05-2012 |
20120010295 | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases - The invention relates to a combination comprising the renin inhibitor of formula (I) | 01-12-2012 |
20120016035 | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases - The invention relates to a combination comprising the renin inhibitor of formula (I) | 01-19-2012 |
20120071470 | PHARMACEUTICAL COMPOSITION COMPRISING A RENIN INHIBITOR, A CALCIUM CHANNEL BLOCKER AND A DIURETIC - The invention relates to a pharmaceutical composition comprising (i) a renin inhibitor, (ii) a calcium channel blocker (CCB), and a diuretic and to a method of using such composition for the treatment of cardiovascular disease. | 03-22-2012 |
20120115854 | PHARMACEUTICAL COMPOSITION CONTAINING ANTIHYPERTENSIVE AGENTS - The present invention relates to a combination of organic compounds, a pharmaceutical composition and a kit of parts comprising said combination of organic compounds and to a method of treatment or prevention of certain conditions or diseases. | 05-10-2012 |
20120138506 | METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITION - The invention relates a pharmaceutical composition comprising a combination of (i) the AT 1-antagonist valsartan or a pharmaceutically acceptable salt thereof and (ii) a NEP inhibitor or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier and to a method for the treatment or prevention of selected conditions or diseases. | 06-07-2012 |
20120142638 | COMBINATION OF ORGANIC COMPOUNDS - The present invention relates to a combination, such as a combined preparation or pharmaceutical composition, respectively, comprising a therapeutic agent acting on the renin-angiotensin system (RAS) or a pharmaceutically acceptable salt thereof and comprising at least one CB1 antagonist, or a pharmaceutically acceptable salt thereof. | 06-07-2012 |
20130158085 | METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITION - The invention relates a pharmaceutical composition comprising a combination of:
| 06-20-2013 |
20130158086 | METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITION - The invention relates a pharmaceutical composition comprising a combination of:
| 06-20-2013 |
20130196977 | USE OF ORGANIC COMPOUNDS - The present invention provides methods for the prevention of, delay progression to overt to, or the treatment of diastolic dysfunction or diastolic heart failure which method comprises administering to a warm-blooded animal a therapeutically effective amount of a renin inhibitor, or a pharmaceutically acceptable salt thereof, alone or in combination with
| 08-01-2013 |